Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · GAUDIUMIVF

GAUDIUMIVF

HealthcareHealthcare Services₹710 cr market cap
₹98.76 ▲ +1.4% today As of 19 Nov 2026
52-week low ₹70.6752-week high ₹158.16

-38.4% from the 52-week high · +37.8% above the low

Gaudium IVF & Women Health Ltd operates fertility and reproductive healthcare centers offering IVF and related treatments. The company provides services such as in vitro fertilization (IVF), IUI treatments, fertility preservation, gynecology consultations, and women’s health diagnostics. Its business model is based on specialized fertility clinics and patient-centric treatment programs. The company also offers advanced reproductive technologies and personalized fertility care. It primarily serves couples seeking infertility treatment and women’s healthcare services.

The short version. Return on equity was 16.1% in Mar 2026. Promoter holding was 71.29% in Sep 2026, up 0.00 points over 4 quarters.

1 · The price

How has the stock traded?

GAUDIUMIVF trades 38.4% below its 52-week high and 37.8% above its 52-week low.

Change over period: —

1M-0.2%
3M-16.0%
6M-13.8%
1Y—

2 · The business

Is it growing?

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025
Revenue37193025
Net profit9284
Net margin %25.29.227.514.8
EPS (₹)1.290.241.150.5

Annual

FY2026
Revenue104
Net profit24
Net margin %23.4
EPS (₹)3.36

3 · The quality

How well does it turn capital into profit?

Return on equity was 16.1% in Mar 2026; debt to equity is 0.15.

Profitability · 1 years

Returns and margins

Mar 2026
Return on equity %16.1
Return on capital %23.1
EBITDA margin %36.4
Net margin %23.3

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Debt to equity0.15
Interest cover10.2x
Current ratio1.90
P/E ratio25.0

4 · The owners

Who holds it, and are they adding?

Promoter holding71.29%

Unchanged over 4 quarters.

Foreign institutions1.19%

Down 8.05 pts over 4 quarters.

Domestic institutions2.22%

Down 2.89 pts over 4 quarters.

Mutual fund schemes2

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter71.2971.2971.2971.290.0
FII9.246.73.021.19-8.05
DII5.112.622.222.22-2.89
Public14.3619.3923.4725.29+10.93

Mutual fund holdings · Oct 2026

2 schemes hold this stock

2 the month before.

  • Motilal Oswal BSE Healthcare ETF0.01% of NAV
  • Bandhan BSE Healthcare Index Fund0.01% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for GAUDIUMIVF are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about GAUDIUMIVF

What is the GAUDIUMIVF share price?

GAUDIUMIVF (GAUDIUMIVF) last closed at ₹98.76, up 1.4% on the day. Its 52-week range is ₹70.67 to ₹158.16.

What is the market cap of GAUDIUMIVF?

GAUDIUMIVF has a market capitalisation of about ₹710 crore. Its price-to-earnings ratio is 25.0.

How are GAUDIUMIVF's latest results?

Return on equity was 16.1% in Mar 2026. Promoter holding was 71.29% in Sep 2026, up 0.00 points over 4 quarters.

Who owns GAUDIUMIVF?

As of Sep 2026, shareholding was: Promoter 71.29%, FII 1.19%, DII 2.22%, Public 25.29%.

How many mutual funds hold GAUDIUMIVF?

2 mutual fund schemes held GAUDIUMIVF in October 2026. That compares with 2 the month before.

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.